• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区获得性感染的流行病学概况:一项系统评价和荟萃分析。

Epidemiologic profile of community-acquired infections: a systematic review and meta-analysis.

作者信息

Álvarez-Villalobos Neri Alejandro, Ruiz-Hernandez Fernando Gerardo, Méndez-Arellano Ana Camila, Azamar-Márquez Jhoan Manuel, Camacho-Ortiz Adrián

机构信息

Facultad de Medicina, Universidad Autónoma de Nuevo León, Av. Dr. José Eleuterio González 235, Mitras Centro, 64460Monterrey, Nuevo León, México.

Centro de Análisis Avanzado de Información 360 (KER Unit México), Universidad Autónoma de Nuevo León, Av. Dr. José Eleuterio González 235, Mitras Centro, 64460Monterrey, Nuevo León, México.

出版信息

Epidemiol Infect. 2025 Mar 4;153:e46. doi: 10.1017/S0950268825000202.

DOI:10.1017/S0950268825000202
PMID:40033994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11920921/
Abstract

's epidemiology has evolved over the past decades, being recognized as an important cause of disease in the community setting. Even so, there has been heterogeneity in the reports of CA-CDI. Therefore, the aim of this study was to assess the epidemiologic profile of CA-CDI.This systematic review and meta-analysis were conducted according to PRISMA checklist and Cochrane guidelines (CRD42023451134). Literature search was performed by an experienced librarian from inception to April 2023, searching in databases like MEDLINE, Scopus, Web of Science, EMBASE, CCRCC, CDSR, and ClinicalTrials. Observational studies that reported prevalence, incidence of CA-CDI, or indicators to calculate them were included. Pool analysis was performed using a binomial-normal model via the generalized linear mixed model. Subgroup analysis and publication bias were also explored. A total of 49 articles were included, obtaining a prevalence of 5% (95% CI 3-8) and an incidence of 7.53 patients (95% CI 4.45-12.74) per 100,000 person-years.In conclusion, this meta-analysis underscores that among the included studies, the prevalence of CA-CDI stands at 5%, with an incidence rate of 7.3 cases per 100,000 person-years. Noteworthy risk factors identified include prior antibiotic exposure and age.

摘要

在过去几十年中,[疾病名称]的流行病学情况不断演变,已被公认为社区环境中疾病的重要病因。即便如此,社区获得性艰难梭菌感染(CA-CDI)的报告仍存在异质性。因此,本研究旨在评估CA-CDI的流行病学特征。

本系统评价和荟萃分析按照PRISMA清单和Cochrane指南(CRD42023451134)进行。由一名经验丰富的图书馆员从研究起始至2023年4月进行文献检索,检索MEDLINE、Scopus、Web of Science、EMBASE、CCRCC、CDSR和ClinicalTrials等数据库。纳入报告CA-CDI患病率、发病率或计算这些指标的观察性研究。通过广义线性混合模型使用二项式正态模型进行汇总分析。还探讨了亚组分析和发表偏倚。共纳入49篇文章,得出患病率为5%(95%置信区间3%-8%),发病率为每10万人年7.53例(95%置信区间4.45-12.74例)。

总之,这项荟萃分析强调,在所纳入的研究中,CA-CDI的患病率为5%,发病率为每10万人年7.3例。已确定的值得注意的风险因素包括既往抗生素暴露和年龄。

相似文献

1
Epidemiologic profile of community-acquired infections: a systematic review and meta-analysis.社区获得性感染的流行病学概况:一项系统评价和荟萃分析。
Epidemiol Infect. 2025 Mar 4;153:e46. doi: 10.1017/S0950268825000202.
2
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
3
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
4
Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis.儿童艰难梭菌感染的危险因素:系统评价和荟萃分析。
J Hosp Infect. 2022 Dec;130:112-121. doi: 10.1016/j.jhin.2022.09.004. Epub 2022 Sep 13.
5
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
6
Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis.共病、药物暴露与社区获得性艰难梭菌感染风险:一项系统评价和荟萃分析
Infect Control Hosp Epidemiol. 2015 Feb;36(2):132-41. doi: 10.1017/ice.2014.39.
7
Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.胃酸抑制与艰难梭菌反复感染的关联:一项系统评价和荟萃分析。
JAMA Intern Med. 2017 Jun 1;177(6):784-791. doi: 10.1001/jamainternmed.2017.0212.
8
Real-world use of bezlotoxumab to prevent recurrent infections: a single-center experience and meta-analysis.贝佐妥单抗预防反复感染的真实世界应用:单中心经验及荟萃分析
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251346593. doi: 10.1177/17562848251346593. eCollection 2025.
9
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.益生菌用于预防成人和儿童艰难梭菌相关性腹泻
Cochrane Database Syst Rev. 2013 May 31(5):CD006095. doi: 10.1002/14651858.CD006095.pub3.
10
Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.质子泵抑制剂治疗与艰难梭菌感染风险:系统评价和荟萃分析。
World J Gastroenterol. 2017 Sep 21;23(35):6500-6515. doi: 10.3748/wjg.v23.i35.6500.

本文引用的文献

1
Incidence, Attributable Mortality, and Healthcare and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees.美国医疗保险优势计划参保者中艰难梭菌感染的发病率、归因死亡率,以及医疗保健和自付费用。
Clin Infect Dis. 2023 Feb 8;76(3):e1476-e1483. doi: 10.1093/cid/ciac467.
2
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019.加拿大 2015-2019 年成人相关医疗保健和社区获得性艰难梭菌感染的特征
Emerg Infect Dis. 2022 Jun;28(6):1128-1136. doi: 10.3201/eid2806.212262. Epub 2022 Apr 26.
3
Epidemiology of Clostridioides difficile infection in hospitalized patients in Spain: An eight-year review (2012-2019).
西班牙住院患者艰难梭菌感染的流行病学:八年回顾(2012-2019)。
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Mar;40(3):125-130. doi: 10.1016/j.eimce.2021.04.008.
4
Linkage study of surveillance and hospital admission data to investigate Clostridium difficile infection in hospital patients in Perth, Western Australia.西澳大利亚州珀斯医院患者艰难梭菌感染的监测和住院数据的连锁研究。
Anaerobe. 2022 Apr;74:102528. doi: 10.1016/j.anaerobe.2022.102528. Epub 2022 Jan 31.
5
Clostridioides difficile infection in a rural New Zealand secondary care centre: an incidence case-control study.新西兰农村二级保健中心艰难梭菌感染:一项发病病例对照研究。
Intern Med J. 2022 Jun;52(6):1009-1015. doi: 10.1111/imj.15220. Epub 2022 May 31.
6
ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.2004 年至 2018 年,ribotypes 001 和 126 在德黑兰医疗保健环境中占主导地位:一项长达 14 年的横断面研究。
Emerg Microbes Infect. 2020 Dec;9(1):1432-1443. doi: 10.1080/22221751.2020.1780949.
7
Increased Community-Associated Clostridioides difficile Infections in Quebec, Canada, 2008-2015.2008-2015 年加拿大魁北克省社区相关性艰难梭菌感染增加。
Emerg Infect Dis. 2020 Jun;26(6):1291-1294. doi: 10.3201/eid2606.190233.
8
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
9
Epidemiology and Risk Factors for Community Associated Clostridioides difficile in Children.儿童社区获得性艰难梭菌感染的流行病学和危险因素。
J Pediatr. 2020 Jun;221:99-106. doi: 10.1016/j.jpeds.2020.02.005. Epub 2020 Mar 11.
10
Clostridium difficile Infection in Children: Epidemiology and Trend in a Swedish Tertiary Care Hospital.儿童艰难梭菌感染:瑞典一家三级保健医院的流行病学和趋势。
Pediatr Infect Dis J. 2019 Dec;38(12):1208-1213. doi: 10.1097/INF.0000000000002480.